Status:
RECRUITING
Expiratory Flow Accelerator (Efa) vs Efa + High Flow in Chronic COPD and Bronchiectasis
Lead Sponsor:
Azienda Socio Sanitaria Territoriale della Valle Olona
Conditions:
Copd
Bronchiectasis Adult
Eligibility:
All Genders
18-95 years
Phase:
NA
Brief Summary
The aim of the study is to compare the efficacy of using EFA technology versus the combination of EFA + high flow in hypersecretory patients COPD and bronchiectasis
Detailed Description
After being informed about the study and potential risks, all patients giving written informed consent will undergo a 13-weeks trial period: 6 weeks of one technology (EFA / EFA+ HIGH FLOW), 1- wash o...
Eligibility Criteria
Inclusion
- COPD diagnosed by spirometry
- Bronchiectasis diagnosed by CT
- 2 Exacerbation/year
Exclusion
- Cystic Fibrosis
- OSAS
- Non Invasive Ventilation
- Ineffective Cough
- Exacerbation in progress
- Hemodynamic Instability
- severe heart failure
Key Trial Info
Start Date :
October 9 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 18 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06017739
Start Date
October 9 2023
End Date
January 18 2025
Last Update
February 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marianna Messina
Somma Lombardo, Varese, Italy, 21019